Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.62 |
| ▸ | MMP9 | P14780 | 1/20 | 0.51 |
| ▸ | MMP8 | P22894 | 1/20 | 0.51 |
| ▸ | MMP14 | P50281 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.49 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.39 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28477059 | 0.87 | CYP3A4 (0.61) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL28251035 | 0.86 | CYP3A4 (0.55) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL28788514 | 0.86 | CYP3A4 (0.58) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL15806949 | 0.86 | CYP3A4 (0.69) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL1835296 | 0.86 | CYP3A4 (0.74) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL5636019 | 0.85 | CYP3A4 (0.59) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL7548470 | 0.84 | CYP3A4 (0.57) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL3432858 | 0.84 | CYP3A4 (0.71) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL5469162 | 0.84 | CYP3A4 (0.78) | CYP3A4MMP9MMP8MMP14ALDH1A1 | |
| SCHEMBL11905467 | 0.84 | CYP3A4 (0.71) | CYP3A4MMP9MMP8MMP14ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10336966-B2 | Fragrance compositions and uses thereof | THE PROCTER & GAMBLE COMPANY (US) | 2019-07-02 | — | — | US | claimed |
| US-12508218-B2 | Coating compositions | COTY INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-3103523-B1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | PROCTER & GAMBLE (US) | 2025-10-29 | — | — | EP | disclosed |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | COTY INC. | 2025-05-15 | — | — | US | disclosed |
| US-20250127707-A1 | FRAGRANCE FORMULATION | COTY INC. | 2025-04-24 | — | — | US | disclosed |
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | COTY INC. | 2025-01-30 | — | — | US | disclosed |
| US-12178896-B2 | Fragrance compositions and uses thereof | COTY INC. (US) | 2024-12-31 | — | — | US | disclosed |
| US-20230285261-A1 | FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR | JPMORGAN CHASE BANK, N.A. | 2023-09-14 | — | — | US | disclosed |
| EP-3141239-B1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | PROCTER & GAMBLE (US) | 2023-05-10 | — | — | EP | disclosed |
| US-20220304914-A1 | COATING COMPOSITIONS | JPMORGAN CHASE BANK, N.A. | 2022-09-29 | — | — | US | disclosed |
| US-20160376525-A1 | Fragrance Compositions and Uses Thereof | PROCTER & GAMBLE (US) | 2016-12-29 | — | — | US | disclosed |
| US-20160362630-A1 | Fragrance Compositions and Uses Thereof | THE PROCTER & GAMBLE COMPANY | 2016-12-15 | — | — | US | disclosed |
| WO-2016200761-A2 | FRAGRANCE COMPOSITIONS AND USES THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-15 | — | — | WO | disclosed |
| WO-2016200760-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | THE PROCTER & GAMBLE COMPANY (US) | 2016-12-15 | — | — | WO | disclosed |
| EP-3103431-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | The Procter and Gamble Company (US) | 2016-12-14 | — | — | EP | disclosed |
| EP-3103523-A1 | ABSORBENT ARTICLE COMPRISING FRAGRANCE COMPOSITION | The Procter and Gamble Company (US) | 2016-12-14 | — | — | EP | disclosed |
| WO-2016001560-A1 | IMPROVED PERFUMING COMPOSITION | LVMH RECHERCHE (FR) | 2016-01-07 | — | — | WO | disclosed |
| US-7196052-B2 | Fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| US-20030216283-A1 | Fragrance composition | TAKASAGO INTERNATIONAL CORPORATION | 2003-11-20 | — | — | US | disclosed |
| JP-2003238985-A | PERFUME COMPOSITION | TAKASAGO INTERNATL CORP | 2003-08-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220304914-A1 | COATING COMPOSITIONS | OR10J3, OR51E2, TAS2R20 | CYP3A4 3559/4885MMP9 2347/4885MMP8 2652/4885 |
| US-12178896-B2 | Fragrance compositions and uses thereof | FHIT, ALG3, FEM1B | CYP3A4 1548/4885MMP9 3585/4885MMP8 3017/4885 |
| US-20250032371-A1 | ETHANOL-FREE FRAGRANCE CHASSIS | OR51E2, FDFT1, ELANE | CYP3A4 295/4885MMP9 3439/4885MMP8 455/4885 |
| US-20250127707-A1 | FRAGRANCE FORMULATION | PUF60, POLM, ADH5 | CYP3A4 973/4885MMP9 2297/4885MMP8 1723/4885 |
| US-20230285261-A1 | FRAGRANCE COMPOSITION COMPRISING A FRAGRANCE COMPONET AND A NON-ODOROUS FRAGRANCE MODULATOR | OR51E2, TRPA1, FAM120A | CYP3A4 1218/4885MMP9 3109/4885MMP8 3802/4885 |
| US-20160362630-A1 | Fragrance Compositions and Uses Thereof | CUTA, DPM1, PLIN5 | CYP3A4 1049/4885MMP9 3584/4885MMP8 1513/4885 |
| US-10336966-B2 | Fragrance compositions and uses thereof | CUTA, DPM1, PLIN5 | CYP3A4 1049/4885MMP9 3584/4885MMP8 1513/4885 |
| US-20030216283-A1 | Fragrance composition | FAAH2, FAAH, DGAT1 | CYP3A4 1063/4885MMP9 3678/4885MMP8 2236/4885 |
| US-12508218-B2 | Coating compositions | TAS2R40, TAS2R20, TAS2R10 | CYP3A4 1938/4885MMP9 2939/4885MMP8 3513/4885 |
| US-20250152487-A1 | FRAGRANCE COMPOSITIONS AND USES THEREOF | FHIT, ALG3, FEM1B | CYP3A4 1548/4885MMP9 3585/4885MMP8 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.